There needs to be a bigger conversation on this:
Read more
Psychedelics and Dying
Can psychedelics help the dying? How science is reviving this ancient connection with death and psychedelics.
Read morePsychedelic Use Rising
Psychedelic use on the rise as Gen Z seeks to ‘enhance connectedness’.
The latest data shows the highest rates of psychedelic use among college students since 1982.
Read morePsychedelics and End of Life
‘The End In Mind’ conference answers questions about psychedelics for end-of-life patients.
Read morePsychedelics Going Mainstream
The growing legitimacy of psychedelics as therapies promises to transform how we view the extraordinary.
Read moreAre Doctors Ready for Psychedelics?
Psychedelic treatments are here, but doctors aren’t prepared.
So says Rick Doblin, founder and executive director of the Multidisciplinary Assn. for Psychedelic Studies.
Read moreWhy Do We Try to Change Our Consciusness?
Here is an interview with author Michael Pollan, discussing psychedelics and the human desire to change our consciousness.
Read moreResearch on Psilocybin and DMT
Contemplating a psychedelic “trip”?
Here is all you need to know about two of your options: Psilocybin vs. DMT.
Read morePodcast on Psychedelics
How Psychedelic Drugs Are Making a Comeback to Treat Depression
The hallucinogenic compound psilocybin is undergoing a renaissance-not as a recreational drug but as a potential treatment for mental health conditions. This podcast follows the journey of one participant of a scientific study into the psychedelic drug's effect on depression.
Read moreWearable Psychedelics?
Wearable psychedelics could soon give users maximum control over their trip.
Scientists are working on a pharmaceutical device to help give people the best possible experiences on the likes of DMT and LSD.
Read moreLatest Research on Psychedelics and Depression
Here’s the latest on how there is a shift in psychiatry toward a new way of thinking about depression, its causes, and therapies.
The profession’s long embrace of the “monoamine hypothesis” — the idea that depression primarily results from abnormal levels of neurotransmitter chemicals in the brain and that drugs can restore the proper balance — is giving way to a more complex understanding and alternative treatments, from ketamine to psychedelics to magnetic stimulation.
Read more